Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Laurus Labs Ltd (Laurus) is an innovative medicines development company that manufactures active pharmaceutical ingredients (API). It carries out the manufacturing of generic finished dosage forms and natural ingredients. Laurus offers active pharmaceutical ingredients and intermediates for anti-retroviral and Hepatitis C, oncology, and other therapeutic areas. The company manufactures ingredients for use in nutraceuticals, dietary supplements and cosmeceutical products. It also offers drug substance, analytical development, synthesis services and product development services. The company operates in India, the UK, Germany, and the US, among others. Laurus is headquartered in Hyderabad, Telangana, India.
Headquarters
India
Address
Serene Chambers, Road No 7, Banjarahills, Hyderabad, Telangana, 500034
Website
www.lauruslabs.com
Telephone
91 40 39804333
No of Employees
5,753
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
LAURUSLABS (NSE)
Revenue (2023)
$769.8M
22.4%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
-4.5%
(2023 vs 2022)
Market Cap*
$2.9B
Net Profit Margin (2023)
XYZ
-22.0%
(2023 vs 2022)
* As of and is in US$
Products and Services
| Products | Services |
|---|---|
| Active Pharmaceutical Ingredients and Intermediates | Drug Substance Services |
| Intermediates | Analytical Development |
| Nutraceutical and Dietary Ingredients | Synthesis Services |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In January, the company and Krka dd Novo Mesto entered into a joint venture agreement to establish Krka Pharma Pvt. Ltd., a joint venture company, in Hyderabad, Telangana, India. |
| 2023 | Acquisitions/Mergers/Takeovers | In November, the company acquired 87.59% stake in Laurus Bio Private. |
| 2023 | Contracts/Agreements | In May, the company entered into an agreement to acquire 7.24% stake in ImmunoACT. |
Competitor Comparison
| Key Parameters | Laurus Labs Ltd | Aurobindo Pharma Ltd | Dr. Reddy's Laboratories Ltd | Divi's Laboratories Ltd | Hikal Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Hyderabad | Hyderabad | Hyderabad | Hyderabad | Mumbai |
| State/Province | Telangana | Telangana | Telangana | Telangana | Maharashtra |
| No. of Employees | 5,753 | 15,690 | 24,832 | 16,950 | 2,142 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Satyanarayana Chava | Director; Chief Executive Officer | Executive Board | 2006 | 62 |
| Venkata Ravi Kumar Vantaram | Director; Chief Financial Officer | Executive Board | 2006 | 58 |
| Venkata Lakshmana Rao Chunduru | Director; Director - Quality | Executive Board | 2018 | 61 |
| Chandrakanth Chereddi | Director | Executive Board | 2016 | - |
| V Uma Maheswer Rao | Executive Vice President - Chemical Research and Development | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer